Katharina Kranzer is Professor of Infectious Disease Epidemiology in the Department of Clinical Research at the London School of Hygiene & Tropical Medicine (LSHTM), where she leads a multidisciplinary research programme focused on tuberculosis (TB), multimorbidity and health systems strengthening. She plays a central role in developing and leading large international research and capacity-building initiatives including a EDCTP funded research training network (SOFAR) with partner institutions in Zambia, Zimbabwe and Mozambique. She supervises doctoral and postdoctoral researchers, and contributes to institutional leadership and training programmes. She also serves as Director of the Health Research Unit Zimbabwe (THRU-Zim) at the Biomedical Research and Training Institute (BRTI), strengthening research partnerships, clinical research delivery and capacity development across southern Africa.Previously, she held a range of academic, clinical and leadership roles across Europe and Africa. These include Clinical Associate Professor at LSHTM, Clinical Director of the National and Supranational Tuberculosis Reference Laboratory in Germany, and senior scientist and group leader in mycobacterial diagnostics at the Research Centre Borstel. She has also worked extensively as a clinician-scientist in the UK and southern Africa. Her work has consistently combined clinical research, laboratory science and capacity strengthening in high TB-burden settings. She has served on multiple WHO TB guidelines groups and is the chair of the scientific conference committee of the The Union World Conference on Lung Health. Katharina trained in medicine at the Technical University of Munich and completed specialist clinical training in medical microbiology and virology in the UK. She holds multiple postgraduate qualifications from LSHTM, including an MSc in Tropical Medicine, an MSc in Epidemiology and a PhD in Epidemiology, as well as membership and fellowship of the Royal College of Physicians and Royal College of Pathologists. During her PhD studies which were focused on the role of active case finding and antiretroviral therapy on TB epidemiology in high TB-HIV burden settings she was based at the University of Cape Town. She has received numerous international awards for research and leadership in global health and tuberculosis, reflecting her longstanding commitment to training and collaborative research across Europe and Africa.